home / stock / evok / evok quote
Last: | $0.432 |
---|---|
Change Percent: | -3.46% |
Open: | $0.4325 |
Close: | $0.4475 |
High: | $0.449 |
Low: | $0.432 |
Volume: | 7,951 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.432 | $0.4325 | $0.4475 | $0.449 | $0.432 | 7,951 | 04-25-2024 |
$0.4475 | $0.43452 | $0.4475 | $0.45 | $0.431 | 9,013 | 04-24-2024 |
$0.4435 | $0.46 | $0.4435 | $0.48 | $0.441 | 4,804 | 04-23-2024 |
$0.455 | $0.497 | $0.455 | $0.5499 | $0.455 | 11,182 | 04-22-2024 |
$0.4685 | $0.498 | $0.4685 | $0.503 | $0.4685 | 1,943 | 04-19-2024 |
$0.4788 | $0.549 | $0.4788 | $0.569899 | $0.4788 | 21,941 | 04-18-2024 |
$0.549 | $0.49 | $0.549 | $0.55 | $0.435 | 20,068 | 04-17-2024 |
$0.47 | $0.465 | $0.47 | $0.48 | $0.4159 | 25,436 | 04-16-2024 |
$0.4752 | $0.521 | $0.4752 | $0.547 | $0.47 | 26,133 | 04-15-2024 |
$0.51 | $0.5374 | $0.51 | $0.539999 | $0.5 | 32,588 | 04-12-2024 |
$0.5401 | $0.59 | $0.5401 | $0.6152 | $0.512 | 44,919 | 04-11-2024 |
$0.5775 | $0.5502 | $0.5775 | $0.589999 | $0.5502 | 10,891 | 04-10-2024 |
$0.53 | $0.561 | $0.53 | $0.5985 | $0.52 | 43,721 | 04-09-2024 |
$0.56 | $0.6 | $0.56 | $0.6 | $0.56 | 10,907 | 04-08-2024 |
$0.5853 | $0.5826 | $0.5853 | $0.5999 | $0.5605 | 17,477 | 04-05-2024 |
$0.6052 | $0.58 | $0.6052 | $0.61 | $0.57 | 27,572 | 04-04-2024 |
$0.62 | $0.601 | $0.62 | $0.645 | $0.58 | 20,368 | 04-03-2024 |
$0.6128 | $0.5844 | $0.6128 | $0.65 | $0.58 | 21,957 | 04-02-2024 |
$0.59 | $0.67 | $0.59 | $0.675 | $0.58 | 49,777 | 04-01-2024 |
$0.61 | $0.5901 | $0.61 | $0.6483 | $0.5901 | 30,344 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced it will host a virtua...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily ...
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...